Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3625345 | Modified Messenger Rna Comprising Functional Rna Elements | MODERNATX, INC. | Feb 23, 2024 |
EP4023755 | Artificial Nucleic Acid Molecules For Improved Protein Expression | CUREVAC AG | Dec 6, 2023 |
EP4066819 | Small Liposomes For Delivery Of Immunogen-Encoding Rna | GLAXOSMITHKLINE BIOLOGICALS SA | Nov 30, 2023 |
EP3521456 | Methods And Means For Enhancing Rna Production | CUREVAC AG | Oct 4, 2023 |
EP3458083 | Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof | MODERNATX, INC. | Aug 2, 2023 |
EP3324979 | Infectious Disease Vaccines | MODERNATX, INC. | Jul 10, 2023 |
EP3708668 | Artificial Nucleic Acid Molecules For Improved Protein Expression | CUREVAC AG | Apr 27, 2023 |
EP2791160 | Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions | MODERNA THERAPEUTICS, INC. | Dec 2, 2022 |
EP3283125 | Lyophilization Of Rna | CUREVAC AG | Sep 29, 2022 |
EP3590949 | Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof | MODERNATX, INC. | Sep 23, 2022 |
Patent Number | Grant Date | Title | Total Oppositions |
---|---|---|---|
EP3892295 | Apr 26, 2023 | Individualized Vaccines For Cancer | 1 |
EP3445850 | Oct 27, 2021 | Methods For Providing Single-Stranded Rna | 1 |
EP3473267 | Sep 8, 2021 | Individualized Vaccines For Cancer | 1 |
EP2714071 | Jul 10, 2019 | Individualized Vaccines For Cancer | 3 |
Feel free to send us a message here and we will get back to you